Molecular Formula | C21H23N3O5 |
Molar Mass | 397.42 |
Density | 1.34 |
Melting Point | 118-120℃ |
Boling Point | 548.7±60.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
Appearance | Solid |
Color | Light Yellow to Yellow |
pKa | 7.93±0.50(Predicted) |
Storage Condition | Refrigerator |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.516 ml | 12.581 ml | 25.162 ml |
5 mM | 0.503 ml | 2.516 ml | 5.032 ml |
10 mM | 0.252 ml | 1.258 ml | 2.516 ml |
5 mM | 0.05 ml | 0.252 ml | 0.503 ml |
Overview | 3-[[3-[(dimethylamino) carbonyl]-2-hydroxyphenyl] amino]-4-[[(R)-1-(5-methylfuran-2-yl) propyl] amino] -3-cyclobutene-1, 2-Diketone is an organic chemical substance, which is an effective allosteric antagonist of CXCR1 and CXCR2, and can only be used in scientific research experiments. |
biological activity | Navarixin (SCH-527123, MK-7123, PS-291822) is an effective CXCR2/CXCR1 antagonist with oral bioavailability, IC50 is 2.6 nM and 36 nM respectively. |
target | TargetValue CXCR2 (Cell-free assay) 2.6 nM CXCR1 (Cell-free assay) 36 nM |
Target | Value |
CXCR2 (Cell-free assay) | 2.6 nM |
CXCR1 (Cell-free assay) | 36 nM |